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SUMMARY  
Background: Non-steroidal Anti- inflammatory 
Drugs (NSAID), are among the most widely used and 
misused of all drugs. Though they provide sympto-
matic relief from pain and swelling in chronic joint 
diseases, they may cause renal impairment, especially 
in combination with other nephrotoxic agents.  
Objectives: This study aimed to investigate the pre-
scription pattern of NSAID in the Out-patient Phar-
macy Department of Lagos University Teaching 
Hospital (LUTH), Nigeria.   
Design: A total of 3800 prescriptions containing 
NSAIDs were analyzed for information on drug 
name, the number of NSAIDs per prescription, the 
presence of ACE inhibitors and diuretics alongside 
NSAIDs and NSAIDs prescribed in generic or brand 
names.  
Results: The results showed that Aspirin was the 
most frequently prescribed NSAID (62.2%) and 
68.4% of the NSAIDs prescriptions studied were 
written in generic names. The total number of drugs 
per prescription was in most cases 3 or greater 
(84.6%). There were statistically significant (p ≤ 
0.05) associations between the individual NSAID 
prescribed and whether they were prescribed in ge-
nerics or brand names; individual NSAID prescribed 
and the frequency of co-prescription with an ACE 
inhibitor and a diuretic; types of NSAID prescribed 
and the cost in Naira.  
Conclusion: Though most of the prescribers com-
plied with WHO standard in their prescriptions vis a 
vis generic prescription, avoidance of polypharmacy 
and avoidance of drug interactions and contraindica-
tions, there is obvious need for interventional 
measures or strategies to improve rational prescribing 
for some of the prescribers tailored towards rational 
prescription and use of drugs 
 




Pain affects a person's quality of life and general func-
tioning 1-2 and it is the commonest reason for physician 
consultation.3 The treatment of both pain and inflamma-
tion is primarily through the use of Non-steroidal Anti-
inflammatory Drugs. Non-steroidal Anti- inflammatory 
Drugs commonly called NSAIDs are among the most 
widely used and misused of all drugs.4 Most NSAIDs act 
as non-selective inhibitors of both the cyclooxygenase-1 
(COX-1) and cyclooxygenase-2 (COX-2) isoenzymes. 
 
NSAIDs provide symptomatic relief from pain and 
swelling in chronic joint diseases such as occur in rheu-
matoid arthritis and in more acute inflammatory condi-
tions such as sports injuries, fractures, sprains, acute ar-
thritic pains and other soft tissue injuries. They also pro-
vide relief from post-operative, dental and menstrual 
pain, and from the pain of headaches and migraine.5They 
are also given to neonates whose ductus arteriosus did 
not close within 24 hours of birth. 
 
There are different NSAID formulations available, in-
cluding tablets, injections and gels, and most of these 
NSAIDs are available over the counter (there are now 
more than 50 different NSAIDs on the global market). 
They are often taken without prescription for some types 
of minor aches and pains that are not necessarily indicat-
ed for NSAIDs.6 However, it is important to note that 
virtually all NSAIDs, particularly the 'classic' NSAIDs, 
have significant unwanted effects, especially in the elder-
ly; but the newer agents have fewer adverse ef-
fects.7These agents may cause renal impairment, espe-












Renal failure has been recently known to be a risk if 
the patient is also concomitantly taking an ACE in-
hibitor and a diuretic - the so-called "triple whammy" 
effect.8 Liver problems are also possible with the 
long term use of NSAIDs.9 
 
In Nigeria the exact number of prescriptions of 
NSAIDs-related hospitalization and deaths are not 
known, though their widespread use suggests that the 
adverse effects of these drugs are inevitable. Each 
year, 70 million prescriptions (NSAIDs) are dis-
pensed in the United States, 20 million are dispensed 
in Great Britain and 10 million are dispensed in Can-
ada.10 
 
More so, the use of NSAIDs accounts for an estimat-
ed 76 000 hospitalizations and 7600 deaths in the 
United States11 and 3897 hospitalizations and 365 
deaths in Canada10every year. These hospitalizations 
and deaths are majorly due to ulcer and gastrointesti-
nal bleeding related to NSAID use. Irrational pre-
scribing has further complicated the adverse effects 
from the use of NSAIDs.12  
 
Therefore, this study aimed to investigate the pre-
scription pattern of Non-steroidal Anti-inflammatory 
drugs (NSAIDs) in the Out-patient Pharmacy De-
partment of Lagos University Teaching Hospital, 




Lagos University Teaching Hospital (LUTH) is one 
of the largest Teaching Hospitals in Nigeria, located 
in the South-west region of the country. Lagos is one 
of Nigeria’s most populated states and the principal 
economic centre in Nigeria. LUTH has many phar-
macy units, one of which is the Out-patient Pharmacy 
Department (OPD), where the prescriptions written 
by the doctors of patients who have no need for im-
mediate hospitalization or who have been discharged 
are dispensed. The total number of residents, medical 
officers and consultant doctors in various disciplines 
in LUTH is about 800. All these doctors in one way 
or the other prescribe NSAIDs depending on the 
complaints and presentation of the patients. 
 
Study Design   
Ethical approval was obtained from the Research 
Ethics Committee of the Lagos University Teaching 
Hospital, Lagos-Nigeria. All prescriptions from July 
2009 to January 2010 were obtained from the Out-
patient Pharmacy Department prescription bank. The 
prescriptions containing NSAIDs were separated 
from those without NSAIDs.  
A total of 3800 prescriptions containing NSAIDs were 
analyzed for information like the drug name and 
strength, the quantity prescribed, the number of NSAIDs 
per prescription, the total number of each NSAID pre-
scribed, the presence of ACE inhibitors and diuretics 
alongside with NSAIDs, the presence of anticoagulants 
in the prescriptions, the number of drugs in each pre-
scription, formulation of NSAIDs prescribed and 
NSAIDs prescribed in generic or brand names. The total 
number of prescriptions whether containing NSAIDs or 
not was also noted. 
 
Data analysis 
The 3800 prescriptions obtained from the study were 
analyzed using the EPI-INFO 2002 software programme. 
The data was presented in pie-chart and frequency distri-
bution tables with percentages, and chi-square analysis 
was used to test the significance at p<0.05. 
 
RESULTS 
The results obtained showed that 3800 (22 %) prescrip-
tions contained NSAIDs out of the total 17, 300 (100%) 
prescriptions during the period of the study. 
 
Table 1 shows that Aspirin was the most frequently pre-
scribed NSAID (62.2%) followed by Diclofenac potassi-
um (13.7%) and Tenoxicam and Piroxicam were least 
prescribed (0.1%). Salicylates were the highest pre-
scribed class of NSAIDs (62.2%), followed by Acetic 
acid derivatives (23.1%), Propionic acid derivatives 
(14.1%), Cox-2-selective inhibitors (0.6%) and the enolic 
acid derivatives were the least prescribed (0.1%). 
 
Table 1 Distribution of NSAID prescribed 
NSAID Frequency Percentage 
Aspirin  2364 62.2 
Celecoxib  20 0.5 
Ibuprofen  331 8.7 
Diclofenac Potassium  521 13.7 
Ketoprofen  37 1.0 
Diclofenac Sodium 360 9.5 
Naproxen  162 4.3 
Piroxian  3 0.1 
Tenoxicam  2 0.1 
Total  3800 100 
 
Table 2 shows that 68.4% of the NSAIDs prescriptions 
studied were written in generic while 31.6% were written 
in brand names. Furthermore, the tablet/ capsule formu-
lations were the major forms by which the NSAIDs were 
prescribed (97.9%).  
 
 






Formulations of NSAIDs in injections and syrups 
account for 0.1 % and 0.5 % respectively. Most of the 
prescriptions had only one NSAID per prescription 
(96.2 %), however, some of the prescriptions con-
tained two or more NSAIDs (3.8%).  
 
Table 2 Pattern of NSAID prescription 
Name used for prescription of 
NSAID 
Frequency Percentage 
Generic 2600 68.4 
Brand 1200 31.6 
Total  3800 100  
Form o f NSAID prescribed   
Tablet/Capsule  3720 97.9 
Eye drop 15  0.4  
Topical gel  41 1.1  
Syrup 20 0.5 
Injection 4 0.1 
Total  3800  100  
Number of NSAID per prescrip-
tion   
1  3657 96.2 
≥ 2 143 3.8 
Total  3800 100  
Mean number of drugs per pre-
scription 4.3 ± 1.8  
Median number of drugs per 
prescription 4  
Total number of drugs per pre-
scription   
1  175 4.6  
2  410 10.8  
3  784  20.6  
4  914  24.1  
5  650  17.1  
≥ 6 867 22.0 
Total  3800 100  
 
The total number of drugs per prescription was in 
most cases 3 or greater (84.6%) and the mean number 
of drugs per prescription is 4.3± 1.8. The results re-
vealed that only 0.5 % NSAIDs were prescribed with 
an anti-coagulant while 20.8 % of NSAIDs were pre-
scribed along with an ACE inhibitor and a diuretic. 
 
Table 3 Association between type of NSAID pre-
scribed and the name used for prescription 
Type of NSAID Name used for prescription of NSAID 
(%) 
Generic Brand Total 
Aspirin  1888 (79.9) 476 (20.1) 2364 
Ibuprofen  327 (98.8) 4 (1.2) 331 
Diclofenac Potassium  245 (47.0) 276 (53.0) 521 
Diclofenac Sodium 67 (18.6) 293 (81.4) 360 
Naproxen  47 (29.0) 115 (71.0) 162 
Others 26 (41.9) 36 (58.1) 62 
χ2 = 944.92, df, 5, p = 0.00 
 
Table 3 shows a statistically significant (p ≤ 0.05) 
association between the individual NSAID prescribed 
and whether they were prescribed in generics or 
brand names. Aspirin (79.9 %), Diclofenac potassium 
(47 %), Diclofenac sodium (18.6%) and Naproxen (29%) 
were prescribed in generic.  
 
The results on Table 4 also illustrate a statistically signif-
icant (p ≤ 0.05) association between the individual 
NSAID prescribed and the frequency of co-prescription 
with an ACE inhibitor and a diuretic. Aspirin (31.9%), 
ibuprofen (2.1%), Diclofenac potassium (3.3%) and Di-
clofenac sodium (2.5%) were prescribed with ACE in-
hibitor and a diuretic. 
 
Table 4 Association between type of NSAID prescribed 
and whether it was prescribed with ACE inhibitor plus 
diuretic  
Type of NSAID NSAID was prescribed with ACE 
inhibitor + diuretic (%) 
Yes No Total 
Aspirin  753 (31.9) 1611 (68.1) 2364 
Ibuprofen  7 (2.1) 324 (97.9) 331 
Diclofenac Potassium  17 (3.3) 504 (96.7) 521 
Diclofenac Sodium 9 (2.5) 351 (97.5) 360 
Naproxen  0 (0) 162 (100) 162 
Others 3 (4.8) 59 (95.2) 62 
χ2 = 468.65, df, 5, p = 0.00 
 
Table 5 reveals a significant (p ≤ 0.05) association be-
tween the types of NSAID prescribed and the cost in 
Naira (N). The cost of Aspirin (96.6%), ibuprofen 
(92.4%), Diclofenac potassium (50.9%), Diclofenac so-
dium (32.8%) and Naproxen (5.6%) prescribed were less 
than N500. 
 
Table 5 Association between type of NSAID prescribed 
and cost of NSAID 
 
Type of NSAID Cost of NSAID in Naira (%) 
≤ 500 > 500 Total 
Aspirin  2284 (96.6) 80 (2.4) 2364 
Ibuprofen  306 (92.4) 25 (7.6) 331 
Diclofenac Potassium  265 (50.9) 256 (49.1) 521 
Diclofenac Sodium 118 (32.8) 242 (67.2) 360 
Naproxen  9 (5.6) 153 (94.4) 162 
Others 11 (17.7) 51 (82.3) 62 




Lagos University Teaching Hospital (LUTH) is one of 
the several tertiary institutions in Nigeria established 
mainly for the purpose of conducting research, training 
and performing clinical services. Conducting studies 
showing the prescription patterns of different drugs 












Although no consensus definition for polypharmacy 
has emerged; the definition imbibed describes 
polypharmacy as the concomitant use of 3 or more 
drugs or the use of more drugs than indicated.13 In 
this present study, a high percentage of the prescrip-
tions studied were discovered to contain 3 or more 
drugs. This observation is clear enough to conclude 
that polypharmacy is prevalent among the studied 
prescriptions. Average number of drugs per prescrip-
tion observed in Tanzania was 2.4 as compared to 4.3 
observed in this study in Nigeria.14 
 
 These data are consistent with the general observa-
tion in Nigerian communities where people take nu-
merous drugs daily. The aforementioned event may 
be due to limited knowledge or experience of the 
prescribing doctors in therapeutics. Polypharmacy, 
which is a form of irrational drug use can increase the 
risk of adverse reaction of drugs and drug interac-
tion.15 
 
This study has shown that NSAIDs were contained in 
about 22% of the total number of studied prescrip-
tions, hence it can be inferred that one of every five 
prescriptions contained NSAIDs. This observation is 
consistent with the earlier study of Carson & Willet4, 
which showed NSAIDs to be some of the widely 
prescribed and used drugs. As a matter of fact, 
NSAIDs are drugs that are generally misused and 
owned by most Nigerians without doctors’ prescrip-
tions.  
 
It is a known fact that the route of drug administra-
tion affects the therapeutic outcome, the onset of ac-
tion as well as the adverse effects produced. It has 
been revealed from this study that most of the 
NSAIDs were prescribed for oral administration and 
the oral administration of NSAIDs is always associ-
ated with gastrointestinal ulcerations.  
 
This may explain the high incidence of GIT side ef-
fects that have been observed with NSAIDs usage.16 
There may be need for the co-administration of cyto-
protective agents with NSAIDs and appropriate 
counseling of patients to always take NSAIDs after 
meal. 
 
Prescriptions written in generics have special im-
portance in rational use of drugs as regards to cost, 
safety and efficacy by permitting the identification of 
the products by their scientific names.17 It also makes 
the prescribers, dispensers and users to easily choose 
between many alternatives in terms of quality, price 
or convenience.  
The results of this study revealed 68.4 % of drugs pre-
scribed in Nigeria in generics as compared to 20 % in 
Cyprus.18 This is quite an encouraging observation but 
there is need for improvement so as to comply with the 
World Health Organization’s standard that ALL pre-
scriptions must be written in generics. 
 
Pressure from pharmaceutical companies may be one of 
the reasons for the writing of brand names thus, there is 
need to discourage the pharmaceutical companies from 
unethical influence of doctors’ prescription pattern and 
for doctors’ to also exercise their ethical and professional 
rights in prescribing drugs. As long as the pharmaceuti-
cal companies influence the prescriptions of doctors’, the 
rate of irrational drug use will continue and the irration-
ality in drug use is always at the expense of the patients’ 
safety. 
 
In most of the cases as seen in this study, only one 
NSAID was prescribed per prescription, however, a few 
had 2 or more NSAIDs prescribed together. Taking two 
or more different NSAIDs may not be therapeutically 
beneficial. Such practice multiplies the toxicities of 
NSAIDs with no evidence of improvement in efficacy.19 
The studies of Thomas8 and Rabinowitz & Van- Thiel9 
showed that the risk of severe drug reactions causing 
injury to the liver and acute renal failure was 6 to 7 times 
higher in reported cases of simultaneous use of two 
NSAIDs.  
 
There was also statistically significant (p ≤ 0.05) associa-
tion between the individual NSAID prescribed and the 
frequency of co-prescription with an ACE inhibitor and a 
diuretic. A recent study has shown the contraindication 
that exists in the co-administration of NSAIDs, diuretics 
and angiotensin converting enzyme inhibitors (ACEIs) 
which may result in drug-induced renal failure.8 The use 
of NSAIDs especially aspirin with anticoagulants is con-
traindicated; however it was observed that though contra-
indicated, NSAIDs (0.5 %) were prescribed with antico-
agulants in a few cases in this study.  
 
The statistically significant (p ≤ 0.05) association that 
was observed between the types of NSAIDs prescribed 
and the cost in Naira may justify the result of aspirin as 
the most frequently prescribed NSAID (62.2%) as it is 
extremely cheap. The frequent prescription of aspirin 
may also be due to the role of this drug in cardiovascular 















There is obvious need for adequate training in ration-
al prescribing to inculcate in the prescribers the ap-
propriate habits tailored towards rational prescription 
and use of drugs. More importantly, the consultants 
and senior doctors should regularly review the pre-
scriptions of their resident doctors and junior doctors 
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